AbbVie Inc.
ABBV
$195.22
$6.203.28%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.29B | -22.00M | 1.56B | 1.37B | 1.37B |
| Total Depreciation and Amortization | 2.04B | 2.10B | 2.08B | 2.13B | 2.07B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 890.00M | 5.37B | 1.06B | 2.15B | 350.00M |
| Change in Net Operating Assets | -2.58B | -397.00M | 750.00M | -3.38B | 247.00M |
| Cash from Operations | 1.64B | 7.05B | 5.45B | 2.27B | 4.04B |
| Capital Expenditure | -235.00M | -291.00M | -249.00M | -241.00M | -193.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -538.00M | -1.79B | -8.49B | -843.00M | -9.39B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.00M | 209.00M | 486.00M | -18.00M | -6.00M |
| Cash from Investing | -735.00M | -1.87B | -8.26B | -1.10B | -9.59B |
| Total Debt Issued | 5.59B | 2.00B | 0.00 | 0.00 | 19.97B |
| Total Debt Repaid | -3.03B | -5.76B | -403.00M | -3.35B | -5.11B |
| Issuance of Common Stock | 56.00M | 10.00M | 67.00M | 10.00M | 127.00M |
| Repurchase of Common Stock | -961.00M | -358.00M | -17.00M | -9.00M | -1.32B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.93B | -2.75B | -2.75B | -2.75B | -2.77B |
| Other Financing Activities | 11.00M | 1.00M | 32.00M | 0.00 | -75.00M |
| Cash from Financing | -1.26B | -6.86B | -3.07B | -6.10B | 10.82B |
| Foreign Exchange rate Adjustments | 9.00M | -46.00M | 8.00M | -9.00M | -18.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -349.00M | -1.73B | -5.87B | -4.94B | 5.25B |